Neutral endopeptidase expression in mesangial cells

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 4, Issue 4, 2003, Pages 228-233

  Ebihara, Fabiana ^a   Seno Di Marco, Giovana ^a   Juliano, Maria Aparecida ^a   Casarini, Dulce Elena ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glomeruli; Kidney; Kininases; Mesangial cells; Neutral endopeptidase

Indexed keywords

BRADYKININ; MEMBRANE METALLOENDOPEPTIDASE; MONOCLONAL ANTIBODY; PEPTIDE; THIORPHAN;

ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME PURIFICATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; GEL FILTRATION CHROMATOGRAPHY; GLOMERULUS; HUMAN; HYDROLYSIS; ION EXCHANGE CHROMATOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MESANGIUM CELL; MODULATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PH MEASUREMENT; PRESSOR RESPONSE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEQUENCE ANALYSIS;

EID: 0346258346     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2003.037     Document Type: Article

References (56)

1. Turner AJ, Isaac RE, Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 2001;23:261-9.
2. Kerr MA, Kenny AJ. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem J 1974;137:489-95.
3. Kerr MA, Kenny AJ. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 1974;137:477-88.
4. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978;276:523-6.
5. Matsas R, Fulcher IS, Kenny AJ, Turner AJ. Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 1983;80:3111-15.
6. Erdos EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. Faseb J 1989;3:145-51.
7. Di Marco GS, Quinto BM, Juliano M et al. Purification and characterization of a neutral endopeptidase-like enzyme from human urine. J Hypertens 1998;16:1971-8.
8. Casarini DE, Alves KB, Araujo MS, Stella RC. Endopeptidase and carboxypeptidase activities in human urine which hydrolyze bradykinin. Braz J Med Biol Res 1992;25:219-29.
9. Kuribayashi Y, Majima M, Katori M, Kato H. Major kininases in rat urine are neutral endopeptidase and carboxypeptidase Y-like exopeptidase. Biomed Res 1993;14:191-201.
10. Chiu PJ, Tetzloff G, Romano MT, Foster CJ, Sybertz EJ. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am J Physiol 1991;260:R208-R216.
11. Margulies KB, Cavero PG, Seymour AA, Delaney NG, Burnett JC, Jr. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int 1990;38:67-72.
12. Sonnenberg JL, Sakane Y, Jeng AY et al. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 1988;9:173-80.
13. Medeiros MA, Franca MS, Boileau G, Juliano L, Carvalho KM. Specific fluorogenic substrates for neprilysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases. Braz J Med Biol Res 1997;30: 1157-62.
14. Richards AM, Wittert GA, Crozier IG et al. Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II. J Hypertens 1993;11:407-16.
15. Burnett JC, Jr.Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens (suppl) 1999;17:S37-S43.
16. Quaschning T, d'Uscio LV, Shaw S, Luscher TF. Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension. Hypertension 2001;37:1108-13.
17. Klapholz M, Thomas I, Eng C et al. Effects of omapatrilat on hemodynamics and safety in patients with heart failure. Am J Cardiol 2001;88:657-61.
18. McClean DR, Ikram H, Garlick AH, Richards AM, Nicholls MG, Crozier IG. The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure. J Am Coll Cardiol 2000;36: 479-86.
19. Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. J Cardiovasc Pharmacol 1998;31:116-25.
20. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-6.
21. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997;29:388-93.
22. Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr Opin Nephrol Hypertens 1997;6:28-34.
23. Chappell MC, Iyer SN, Diz DI, Ferrario CM. Antihypertensive effects of angiotensin-(1-7). Braz J Med Biol Res 1998;31:1205-12.
24. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997;30:535-41.
25. Chansel D, Czekalski S, Pham P, Ardaillou R. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 1992;262:F432-F441.
26. Campos AH, Calixto JB, Schor N. Effects of kinins upon cytosolic calcium concentrations in mouse mesangial cells. Immunopharmacology 1999;45:39-49.
27. Andrade MC, Quinto BM, Carmona AK et al. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J Hypertens 1998;16:2063-74.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
29. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
30. Tambellini R, Di Marco GS, Casarini DE. Comparison of the neutral endopeptidase (NEP-like) profile in urine from wistar and spontaneous hypertensive rats. J Hypertens 2002;20:S262.
31. Muangman P, Spenny ML, Tamura RN, Gibran NS. Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells. Shock 2003;19:508-12.
32. Cushman DW, Gordon EM, Wang FL, Cheung HS, Tung R, Delaney NG. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain. Life Sci 1983;33(suppl 1):25-8.
33. Carvalho KM, Boileau G, Franca MS, Medeiros MA, Camargo AC, Juliano L. A new fluorometric assay for neutral endopeptidase (EC 3.4.24.11). Braz J Med Biol Res 1995;28: 1055-9.
34. Ottlecz A, Walker S, Conrad M, Starcher B. Neutral metalloendopeptidase associated with the smooth muscle cells of pregnant rat uterus. J Cell Biochem 1991;45:401-11.
35. Almenoff J, Orlowski M. Membrane-bound kidney neutral metalloendopeptidase: interaction with synthetic substrates, natural peptides, and inhibitors. Biochemistry 1983;22:590-9.
36. Camargo AC, Ramalho-Pinto FJ, Greene LJ. Brain peptidases: conversion and inactivation of kinin hormones. J Neurochem 1972;19:37-49.
37. Rush RS, Hersh LB. Multiple molecular forms of rat brain enkephalinase. Life Sci 1982;31:445-51.
38. Gafford JT, Skidgel RA, Erdos EG, Hersh LB. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983;22:3265-71.
39. Devault A, Lazure C, Nauk C et al. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. Embo J 1987;6:1317-22.
40. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993;45:87-146.
41. Relton JM, Gee NS, Matsas R, Turner AJ, Kenny AJ. Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem J 1983;215:519-23.
42. Chen CY, Salles G, Seldin MF, Kister AE, Reinherz EL, Shipp MA. Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11). Molecular characterization, chromosomal localization, and modeling of the active site. J Immunol 1992;148:2817-25.
43. Malfroy B, Schofield PR, Kuang WJ, Seeburg PH, Mason AJ, Henzel WJ. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem Biophys Res Commun 1987;144:59-66.
44. Malfroy B, Kuang WJ, Seeburg PH, Mason AJ, Schofield PR. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 1988;229: 206-10.
45. Casarini DE, Boim MA, Stella RC, Schor N. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron. Am J Physiol 1999;277:F66-F74.
46. Erdos EG, Schulz WW, Gafford JT, Defendini R. Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I-converting enzyme. Lab Invest 1985;52:437-47.
47. Tauc M, Chatelet F, Verroust P, Vandewalle A, Poujeol P, Ronco P. Characterization of monoclonal antibodies specific for rabbit renal brush-border hydrolases: application to immunohistological localization. J Histochem Cytochem 1988;36:523-32.
48. Edwards RM, Pullen M, Nambi P. Distribution of neutral endopeptidase activity along the rat and rabbit nephron. Pharmacology 1999;59:45-50.
49. Landry C, Santagata P, Bawab W et al. Characterization of neutral endopeptidase 24.11 in dog glomeruli. Biochem J 1993;291(Pt 3):773-9.
50. Shima M, Seino Y, Torikai S, Imai M. Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. Life Sci 1988;43:357-63.
51. Albrightson CR, Pullen M, Wu HL, Dytko G, Hersh LB, Nambi P. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity. Mol Pharmacol 1995;47:1156-63.
52. Skidgel RA, Schulz WW, Tam LT, Erdos EG. Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int(suppl) 1987;20:S45-S48.
53. Ura N, Carretero OA, Erdos EG. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int 1987;32:507-13.
54. Minshall RD, Tan F, Nakamura F et al. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res 1997;81:848-56.
55. Gohlke P, Linz W, Scholkens BA et al. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23:411-18.
56. Yang XP, Liu YH, Peterson E, Carretero OA. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins. J Cardiovasc Pharmacol 1997;29:250-6.